S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Biden's pick to lead FAA withdraws amid shaky Senate support
Travel disruption hits Germany on eve of transport strike
Modern Day Options Trading For Beginners! (Ad)pixel
Berlin climate proposal fails to get enough yes votes to win
Turkmenistan votes for new, opposition-free parliament
OTCMKTS:SPHS

Sophiris Bio - SPHS Stock Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$4,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SPHS stock logo

About Sophiris Bio (OTCMKTS:SPHS) Stock

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

Receive SPHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter.

SPHS Stock News Headlines

Sophiris Bio Inc. Registered Sh (BFF1.SG)
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
Sophiris Bio Inc (SPHS)
Sophiris Bio, Inc. (SPHS)
Sophiris Bio To Shut Down Operations
Sophiris Bio Inc.
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
Sophiris to delist; shares plummet 42% after hours
Sophiris Bio Announces Nasdaq Delisting
SPHS Feb 2020 2.500 call
Sophiris Bio files for equity offering
Sophiris Bio secures $4M capital raise
Sophiris Bio EPS beats by $0.04
See More Headlines
Receive SPHS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter.

SPHS Company Calendar

Last Earnings
5/09/2019
Today
3/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SPHS
Fax
N/A
Employees
2,018
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4,000.00
Optionable
Not Optionable
Beta
1.94

Key Executives

  • Randall E. Woods
    President & Chief Executive Officer
  • Peter T. Slover
    Chief Financial & Accounting Officer













SPHS Stock - Frequently Asked Questions

How were Sophiris Bio's earnings last quarter?

Sophiris Bio, Inc. (OTCMKTS:SPHS) announced its quarterly earnings results on Thursday, May, 9th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.02.

What is Sophiris Bio's stock symbol?

Sophiris Bio trades on the OTCMKTS under the ticker symbol "SPHS."

How do I buy shares of Sophiris Bio?

Shares of SPHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Sophiris Bio make?

Sophiris Bio (OTCMKTS:SPHS) has a market capitalization of $0.00.

How many employees does Sophiris Bio have?

The company employs 2,018 workers across the globe.

How can I contact Sophiris Bio?

Sophiris Bio's mailing address is 1258 PROSPECT STREET, LA JOLLA CA, 92037. The official website for the company is www.sophirisbio.com. The company can be reached via phone at (858) 777-1760 or via email at cdavis@lifesciadvisors.com.

This page (OTCMKTS:SPHS) was last updated on 3/26/2023 by MarketBeat.com Staff